Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 10Glioblastoma 6Glioma 4Astrocytoma 3Oligodendroglioma 2Neoplasm Metastasis 2Central Nervous System Neoplasms 2Supratentorial Brain Tumor 1Neoplasms 1Melanoma 1Central Nervous System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Radiotherapy 122Temozolomide 110Carboplatin 53Filgrastim 46Vincristine 43Etoposide 39Cyclophosphamide 37Chemotherapy, Adjuvant 37Cisplatin 36Carmustine 32Irinotecan 27Peripheral Blood Stem Cell Transplantation 25Magnetic Resonance Spectroscopy 24Lomustine 22Thiotepa 21Methotrexate 20Granulocyte Colony-Stimulating Factor 18Procarbazine 16Bevacizumab 16Surgical Procedures, Operative 15O(6)-benzylguanine 14etoposide phosphate 13Drug Therapy 13Topotecan 12Paclitaxel 12Ifosfamide 12Thalidomide 11Radiation 11sargramostim 10Specimen Handling 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Craniotomy × Clear all
NCT00293423 2021-05-13

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

University of California, San Francisco

Phase 1/2 Completed
96 enrolled 19 charts
CNS

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms

NCT00905060 2021-03-24

HeatShock

University of California, San Francisco

Phase 2 Completed
70 enrolled 12 charts
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡